Business Development

 

• Strategic Partnerships
• Organisational Development
• Product Development
• Technology Improvement
• Technology Transfer
• Lean Operations

Project Management

 

• API Facility DKK 1,500 mill., Novo Nordisk A/S
• Packaging Line, 130 mill., Novo Nordisk A/S
• API Facility DKK 100 mill., Xellia Pharmaceuticals ApS
• Downstream processing unit DKK 50 mill.,   HemaSure Denmark A/S
• Development of therapeutic proteins through chromatographic purification methods,              Statens Serum Institut
• Plasma Fractionation Plant DKK 40 mill.,              Statens Serum Institut

Line Management

 

• Manager Product Development, Chr. Hansen A/S
• Factory Manager, Orkla Health
• General Manager Engineering, Xellia Pharmaceuticals ApS
• Director Operations, Xellia Pharmaceuticals ApS
• Director R&D, HemaSure Denmark A/S
• Manager Development, Quality Control & Production Support, Novo Nordisk A/S
• Leader/scientific assistant, Statens Serum Institut (SSI)